증례

상악골에 발생한 법랑아세포종 1예

박시영1, 김상철1, 고영승1,*
See Young Park1, Sang Chul Kim1, Young Seung Ko1,*
Author Information & Copyright
1인제대학교 의과대학 일산백병원 이비인후과학교실
1Department of Otolaryngology, Collage of Medicine, Inje University, Ilsan Paik Hospital, Goyang, Korea
*교신저자: 고영승, 411-706 경기도 고양시 일산구 대화동 2240번지 인제대학교 의과대학 일산백병원 이비인후과학교실 전화: (031) 910-7250·전송: (031) 910-7747 E-mail: koys2000@naver.com

© Copyright 2004 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Aug 21, 2004; Accepted: Oct 22, 2004

Published Online: May 31, 2020

ABSTRACT

Ameloblastoma is an unusual epithelial tumor of odontogenic origin. According to many authors and reports, ameloblastoma account for approximately 1% of all tumors of the jaws. It occurs commonly at the mandible and rarely at the maxilla. Clinically, three subtypes are recognized:unicystic, multicystic and peripheral. Although it is considered benign, it can behave in a slowly growing infiltrative fashion, with multiple recurrences and eventual intracranial, or even distant spread. Standard treatment has not yet established. Various modes of therapy have been used, including curettage, cryotherapy, cautery, simple excision, radical excision, radiotherapy. While many investigators feel the only acceptable mode of treatment is radical en bloc resection, there are others who believe a more conservative surgical approach is often adequate. We have experienced a case of ameloblastoma occurring in the maxilla, and treated with medial maxillectomy. So, we present this case with a review of literature. (J Clinical Otolaryngol 2004;15:316-319)

Keywords: 법랑아세포종; 상악골
Keywords: Ameloblastoma; Maxilla


36권 4호 Quiz 및 정답, 해설

정답 ④

설하신경자극술의 핵심 치료 원리는 설하신경의 내측 분지를 선택적으로 
자극하여 이설근(genioglossus muscle)의 전방 돌출을 유도함으로써 
수면 중 상기도의 기능적 개방성을 유지하는 것이다. 기존 Inspire® 시스템은 
흡기 노력 감지 센서를 이용해 자극을 호흡 주기와 동기화하며, Nyxoah Genio® 
시스템은 양측 설하신경을 동시에 자극하는 무배터리 구조를 채택한 최신 장치이다. 
반면 Ansa cervicalis stimulation은 혀가 아닌 인두 구조물의 미측 견인을 통해 
상기도를 안정화시키는 다른 기전을 가진다.

 

* 당첨자 (1명)

이**    010-****-**61

 

응모해 주신 모든분들께 감사드립니다.

경품은 당첨자분들께 2.20(금)까지 개별 발송해 드리겠습니다.

 

임상이비인후과 편집위원회 


I don't want to open this window for a day.